Transforming Care. Person by Person.

Transforming Care.
Person by Person.

Ethicon has been a powerful catalyst for positive change for over a century – and we’re not stopping now. Today, surgeons can create a clear road map for surgery using 3D pre-operative planning.

Patient and Surgeon Views on SSI Prevention

Together, We Can Reduce Surgical Site Infection (SSI) Risk

One action can make a difference in reducing surgical site infection risk. Join the movement and watch these inspiring videos.

Ethicon, part of the Johnson & Johnson Medical Devices Companies, has made significant contributions to surgery for more than 100 years, from creating the first sutures, to revolutionizing surgery with minimally invasive procedures. Our surgical technologies and solutions include sutures, staplers, energy devices, trocars and hemostats along with interventional ablation, robotic and digital solutions.

We are Looking for Change Agents

We are Looking for Change Agents

Let’s change the trajectory of human health. Ethicon, part of the Johnson & Johnson Family of Companies Can Change Everything. Including YOU.

News & Events

Teaser Image

Ethicon’s MONARCH® Endoscopic Robotic Platform Receives FDA 510(k) Clearance for Urology Procedures

Teaser Image

Ethicon Launches Enseal X1 Straight Jaw Tissue Sealer for Stronger Sealing, Greater Efficiency and Easy Access to Targeted Tissue in Multiple Surgical Procedures

New advanced bipolar energy device cuts, transects and seals tissue more securely and with greater efficiency than competitor
Teaser Image

Ethicon’s Echelon Circular Powered Stapler Associated With Major Reduction in Serious Complications Following Colorectal Surgery

Teaser Image

Ethicon Surgical Innovations Lab Kicks Off U.S. Mobile Tour With Visits to Hospitals Nationwide


* CDC, WHO, ACS/SIS, NICE, and KRINKO guidelines on reducing the risk of surgical site infections are general to triclosan-coated sutures and are not specific to any one brand.

1.    Compared to previous generations of Enseal devices (099986-210202).

2.    ENSEAL® X1 Curved Jaw Tissue Sealer can capture, seal and transect a longer length of tissue per single activation due to a 16% (or 3.4mm) longer jaw (p < 0.001) and a 19% (or 3.5mm) longer cut length (p < 0.001) compared to LigaSure™ Maryland (LF1937). (145163-200630).

3.    In benchtop testing on porcine arteries, vessels sealed with ENSEAL® X1 Curved Jaw had a 22% higher average burst pressure than vessels sealed with LigaSure™ Maryland (LF1937), (1055mmHg vs. 862mmHg, p < 0.001). (145079-200629).

4.    112 of 112 vessels sealed successfully on first pass in an acute porcine model. All seals maintained hemostasis during blood pressure challenge. During blood pressure challenge, systolic blood pressure was increased to at least 200 mmHg for a minimum of 10 minutes to simulate a hypertensive crisis. (095317-200519)

5.    Berríos‐Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152(8):784‐791.

6.    WHO Global Guidelines for the Prevention of Surgical Site Infection. Geneva: World Health Organization; 2016.

7.    Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2016;224(1):59‐74.

8.    NICE Guideline Updates Team (UK). Surgical site infection: prevention and treatment. NICE website. Accessed April 3, 2020.

9.    5. Prevention of postoperative wound infections. Recommendation of the Committee for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute. Bundesgesundheitsbl. 2018;61(4):448‐473.

10.    Impact of the Novel Powered Circular Stapler on Risk of Anastomotic Leakage in Colorectal Anastomosis. A Propensity Score‐ Matched Study. [ECHELON CIRCULAR 1.7% (1/60) vs. manual circular 11.8% (14/119), p=0.022]. (153162-200916)